← 產業報告目錄

Nanorobotics Market by Type (Nano-manipulator, Nanorobotic System), Deployment (In-vivo, In-vitro/Ex-vivo, Others), Technology (Magnetic Actuation, Biohybrid/Biological Propulsion, Acoustic/Ultrasound Propulsion, Others)-Global Forecast to 2032

出版商 MarketsandMarkets產業別 Electronics & Semiconductor出版日期 2026-02-05頁數 215報告編號 SE6954

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global nanorobotics market is projected to grow from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, at a CAGR of 10.6% from 2026 to 2032. The growth of the nanorobotics market is expected to be driven by rising government and private investments in nanotechnology R&D, along with expanding collaboration between research institutes and industry players, which are accelerating technology development. In addition, increasing use of nanorobotics in materials science, semiconductor research, and nanoscale manufacturing is supporting market expansion. "By type, the nano-manipulator segment holds the largest share during the forecast period." The nano-manipulators segment of the nanorobotics market is expected to hold the largest market share during the forecast period. Nano-manipulators are well-established tools for precise positioning, probing, and manipulation at the nanoscale, making them essential for materials science, semiconductor research, and life-science studies. Their strong market presence is supported by proven performance, relatively higher technology maturity, and seamless integration into existing research workflows. In addition, continuous demand for high-precision nanoscale analysis and experimentation across academic and industrial settings continues to drive large-scale adoption, reinforcing nano-manipulators’ dominant share in the global nanorobotics market. "Pharma & biotech companies segment expected to register the highest CAGR during the forecast period." The pharma & biotech companies segment is expected to grow at the highest CAGR during the forecast period, driven by growing demand for advanced drug development and precision treatment technologies. Pharma and biotech companies are increasingly adopting nanorobotics systems for targeted drug delivery, nanosurgery, tissue repair, and in vivo research to improve therapeutic efficacy and reduce side effects. Rising investments in biologics, regenerative medicine, and personalized therapies are accelerating the need for exact and controllable nanoscale solutions. "China to be the largest market for nanorobotics in the Asia Pacific." China is expected to continue dominating the nanorobotics market in the Asia Pacific region during the forecast period. The country has established a robust ecosystem of universities, national laboratories, and research institutes actively engaged in nanorobotics development, supporting both in vitro and in vivo applications. In addition, China’s growing pharmaceutical and biotechnology industries are accelerating the adoption of nanorobotics for drug delivery, diagnostics, and next-generation medical research. Strong policy support, increasing R&D investments, and close collaboration between academia and industry further strengthen China’s leadership position, making it the dominant contributor to nanorobotics market growth in the Asia Pacific region. Extensive primary interviews were conducted with key industry experts in the nanorobotics market to determine and verify market sizes across segments and subsegments. The breakdown of primary participants for the report is shown below. The study includes insights from various industry experts, including component suppliers, Tier 1 Companies, and OEMs. The breakup of the primaries is as follows: • By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35% • By Designation: C-level Executives – 35%, Directors – 340%, and Others – 20% • By Region: North America – 25%, Europe – 20%, Asia Pacific – 45%, and RoW – 10% Note: Three tiers of companies are defined based on their total revenue as of 2024: tier 1: revenue of USD 500 million or more; tier 2: revenue between USD 100 million and USD 500 million; and tier 3: revenue of USD 100 million or less. Other designations include sales and marketing executives, researchers, and members of various nanorobotics organizations. JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others, are the key players in the nanorobotics market. The study includes an in-depth competitive analysis of these key players in the nanorobotics market, along with their company profiles, recent developments, and key market strategies. Research Coverage: This research report categorizes the nanorobotics market by type (nano-manipulators and nanorobotics systems), deployment (in vivo, in vitro/ex vivo, and other), technology (magnetic actuation, biohybrid/biological propulsion, acoustic/ultrasound propulsion, and other), application (drug delivery, diagnostics, nano-surgery & tissue repair, and other), end user (hospitals & clinical centers, pharma & biotech companies, research institutes & universities, medical devices OEMs, and other), and region (North America, Europe, Asia-Pacific, and RoW). The report describes the major drivers, restraints, challenges, and opportunities in the nanorobotics market and forecasts the market through 2032. The report also includes leadership mapping and analysis of all the companies included in the nanorobotics market ecosystem. Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall nanorobotics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (rising focus on nanotechnology and regenerative medicine and increasing government support and level of investment in nanorobotics) restraints (Lack of clear regulatory frameworks and high development & manufacturing costs), opportunities (growing demand of oncology and precision therapeutics and increasing use of AI-guided imaging systems enhancing nanorobotics navigation and monitoring) and challenges (commercialization of nanorobotics systems) influencing the growth of the nanorobotics market • Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the nanorobotics market • Market Development: Comprehensive information about lucrative markets – the report analyzes the nanorobotics market across varied regions • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the nanorobotics market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as JEOL LTD. (Japan), Thermo Fisher Scientific Inc. (US), Bruker (Germany), Hitachi High-Tech Corporation (Japan), ZEISS Group (Germany), Oxford Instruments (UK), EV Group (Austria), Park Systems (South Korea), among others in the nanorobotics market
目錄 Table of Contents
1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.3 STUDY SCOPE 25 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 25 1.3.2 INCLUSIONS & EXCLUSIONS 26 1.3.3 YEARS CONSIDERED 26 1.3.4 CURRENCY CONSIDERED 27 1.3.5 UNIT CONSIDERED 27 1.4 STAKEHOLDERS 27 2 EXECUTIVE SUMMARY 28 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 28 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 29 2.3 DISRUPTIVE TRENDS SHAPING NANOROBOTICS MARKET 30 2.4 HIGH-GROWTH SEGMENTS 30 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 31 3 PREMIUM INSIGHTS 32 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NANOROBOTICS MARKET 32 3.2 NANOROBOTICS MARKET, BY TYPE 32 3.3 NANOROBOTICS MARKET, BY APPLICATION 33 3.4 NANOROBOTICS MARKET, BY TECHNOLOGY 33 3.5 NANOROBOTICS MARKET, BY END USER 34 3.6 NANOROBOTICS MARKET, BY COUNTRY 34 4 MARKET OVERVIEW 35 4.1 INTRODUCTION 35 4.2 MARKET DYNAMICS 35 4.2.1 DRIVERS 36 4.2.1.1 Strong healthcare demand for better clinical translation and investment 36 4.2.1.2 Increasing government support and level of investment in nanorobotics 36 4.2.1.3 Rising focus on nanotechnology and regenerative medicine 37 4.2.2 RESTRAINTS 37 4.2.2.1 Lack of clear regulatory frameworks and high development & manufacturing costs 38 4.2.3 OPPORTUNITIES 38 4.2.3.1 Growing demand of oncology and precision therapeutics 38 4.2.3.2 Increasing use of AI-guided imaging systems, enhancing nanorobotics navigation and monitoring 39 4.2.4 CHALLENGES 39 4.2.4.1 Commercialization of nanorobotics systems 39 4.3 UNMET NEEDS & WHITE SPACES 40 4.3.1 UNMET NEEDS IN NANOROBOTICSS MARKET 40 4.3.2 WHITE SPACE OPPORTUNITIES 40 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 40 4.4.1 INTERCONNECTED MARKETS 40 4.4.2 CROSS-SECTOR OPPORTUNITIES 41 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 41 4.5.1 MARKET DYNAMICS FOR NANOROBOTICS MARKET 41 5 INDUSTRY TRENDS 42 5.1 INTRODUCTION 42 5.2 PORTER’S FIVE FORCES ANALYSIS 42 5.2.1 THREAT OF NEW ENTRANTS 43 5.2.2 THREAT OF SUBSTITUTES 43 5.2.3 BARGAINING POWER OF SUPPLIERS 43 5.2.4 BARGAINING POWER OF BUYERS 44 5.2.5 INTENSITY OF COMPETITIVE RIVALRY 44 5.3 MACROECONOMIC OUTLOOK 44 5.3.1 INTRODUCTION 44 5.3.2 GDP TRENDS AND FORECAST 44 5.3.3 TRENDS IN GLOBAL MEDICAL OEMS 46 5.3.4 TRENDS IN GLOBAL HOSPITALS AND CLINICAL CENTERS 46 5.4 VALUE CHAIN ANALYSIS 46 5.5 ECOSYSTEM ANALYSIS 48 5.5.1 ROLE IN ECOSYSTEM 48 5.6 PRICING ANALYSIS 49 5.6.1 AVERAGE SELLING PRICE FOR ELECTRON MICROSCOPES, BY TYPE, 2025 49 5.6.2 AVERAGE SELLING PRICE TREND OF ELECTRON MICROSCOPES, BY TYPE, 2022–2025 50 5.6.3 AVERAGE SELLING PRICE TREND OF SEM ELECTRON MICROSCOPES, BY REGION, 2022–2025 51 5.7 TRADE ANALYSIS 51 5.7.1 IMPORT DATA FOR HS CODE 901210 51 5.7.2 EXPORT DATA FOR HS CODE 901210 52 5.8 KEY CONFERENCES & EVENTS, 2026–2027 53 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 55 5.10 INVESTMENT & FUNDING SCENARIO, 2023–2025 56 5.11 CASE STUDY ANALYSIS 56 5.11.1 KLEINDIEK NANOTECHNIK ENABLING IN-SITU NANO-MANIPULATION INSIDE SEM AND TEM 56 5.12 IMPACT OF 2025 US TARIFF ON NANOROBOTICS MARKET 57 5.12.1 KEY TARIFF RATES 57 5.12.2 PRICE IMPACT ANALYSIS 59 5.12.3 IMPACT ON VARIOUS COUNTRIES/REGIONS 59 5.12.3.1 US 59 5.12.3.2 Europe 59 5.12.3.3 Asia Pacific 60 5.12.4 IMPACT ON END USERS 60 6 TECHNOLOGICAL ADVANCEMENT, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 61 6.1 KEY TECHNOLOGIES 61 6.1.1 NANOMEDICINE AND PRECISION DRUG DELIVERY SYSTEMS 61 6.1.2 BIO-HYBRID AND CELL-DRIVEN NANOROBOTS 61 6.2 COMPLEMENTARY TECHNOLOGIES 61 6.2.1 ADVANCED MEDICAL IMAGING AND NAVIGATION SYSTEMS 61 6.2.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING 61 6.3 ADJACENT TECHNOLOGIES 62 6.3.1 LAB-ON-A-CHIP DEVICES 62 6.4 TECHNOLOGY/PRODUCT ROADMAP 62 6.5 PATENT ANALYSIS 64 6.5.1 LIST OF APPLIED/GRANTED PATENTS 64 6.6 IMPACT OF AI/GEN AI ON NANOROBOTICS MARKET 66 6.6.1 TOP USE CASES AND MARKET POTENTIAL 66 6.6.2 BEST PRACTICES IN NANOROBOTICS MARKET 67 6.6.3 CASE STUDIES OF AI IMPLEMENTATION 67 6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 67 6.6.5 CLIENTS’ READINESS TO ADOPT AI 68 7 REGULATORY LANDSCAPE 69 7.1 INTRODUCTION 69 7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 7.3 STANDARDS AND REGULATIONS RELATED TO NANOROBOTICS 71 7.3.1 STANDARDS 71 7.3.1.1 ISO 71 7.3.1.2 REACH 71 7.3.1.3 NIOSH 71   8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 72 8.1 DECISION-MAKING PROCESS 72 8.2 KEY STAKEHOLDERS & BUYING CRITERIA 73 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 73 8.2.2 BUYING CRITERIA 74 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 75 8.4 UNMET NEEDS FROM VARIOUS END USERS 75 9 NANOROBOTICS MARKET, BY TYPE 77 9.1 INTRODUCTION 78 9.2 NANO-MANIPULATORS 79 9.2.1 ADVANCEMENTS IN NANO-MANIPULATION TECHNOLOGIES TO ACCELERATE RESEARCH AND INDUSTRIAL ADOPTION 79 9.3 NANOROBOTIC SYSTEMS 82 9.3.1 RISING FOCUS ON AUTONOMOUS NANOROBOTICS SYSTEMS TO AID MARKET EXPANSION 82 10 NANOROBOTICS MARKET, BY TECHNOLOGY 85 10.1 INTRODUCTION 86 10.2 MAGNETIC ACTUATION 87 10.2.1 GROWTH OF HEALTHCARE SECTOR TO DRIVE DEMAND FOR MAGNETICALLY ACTUATED NANOROBOTICS 87 10.3 BIOHYBRID/BIOLOGICAL PROPULSION 87 10.3.1 INCREASING FOCUS ON BIOCOMPATIBLE AND AUTONOMOUS NANOROBOTIC SYSTEMS TO PROPEL MARKET GROWTH 87 10.4 ACOUSTIC/ULTRASOUND PROPULSION 87 10.4.1 ADVANCEMENTS IN NON-CONTACT TECHNOLOGIES TO SUPPORT ADOPTION OF ACOUSTIC/ULTRASOUND PROPULSION 87 10.5 OTHER TECHNOLOGIES 88 11 NANOROBOTICS MARKET, BY DEPLOYMENT 89 11.1 INTRODUCTION 90 11.2 IN-VIVO DEPLOYMENT 91 11.2.1 RISING INVESTMENT IN NANOMEDICINE AND TRANSLATIONAL RESEARCH TO AID MARKET GROWTH 91 11.3 IN-VITRO/EX-VIVO DEPLOYMENT 91 11.3.1 CONTINUOUS INVESTMENTS IN LIFE-SCIENCE RESEARCH AND MATERIALS INNOVATION TO AUGMENT MARKET GROWTH 91 11.4 OTHER DEPLOYMENTS 92   12 NANOROBOTICS MARKET, BY APPLICATION 93 12.1 INTRODUCTION 94 12.2 DIAGNOSTICS 95 12.2.1 GROWING ADOPTION OF IN-VITRO DIAGNOSTICS, LAB-ON-CHIP, AND POINT-OF-CARE TESTING TO BOOST MARKET GROWTH 95 12.3 DRUG DELIVERY 96 12.3.1 INCREASING PREVALENCE OF CHRONIC AND COMPLEX DISEASES TO FUEL MARKET GROWTH 96 12.4 NANO SURGERY & TISSUE REPAIR 96 12.4.1 RISING DEMAND FOR MINIMALLY INVASIVE AND HIGH-PRECISION SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH 96 12.5 OTHER APPLICATIONS 97 13 NANOROBOTICS MARKET, BY END USER 98 13.1 INTRODUCTION 99 13.2 RESEARCH INSTITUTES & UNIVERSITIES 100 13.2.1 DEMAND FOR NANO-MANIPULATORS, NANOPROBING SYSTEMS, AND EXPERIMENTAL NANOROBOTIC PLATFORMS TO DRIVE MARKET 100 13.3 HOSPITALS & CLINICAL CENTERS 104 13.3.1 RISING DEMAND FOR MINIMALLY INVASIVE AND PRECISION-GUIDED MEDICAL PROCEDURES TO AID MARKET GROWTH 104 13.4 PHARMA & BIOTECH COMPANIES 108 13.4.1 RISING R&D SPENDING TO IMPROVE DRUG DISCOVERY EFFICIENCY AND SUCCESS RATES 108 13.5 MEDICAL OEMS 112 13.5.1 DEMAND FOR MINIATURIZED AND HIGH-PRECISION MEDICAL DEVICES AND COMPONENTS TO AUGMENT MARKET GROWTH 112 13.6 OTHER END USERS 116 14 NANOROBOTICS MARKET, BY REGION 120 14.1 INTRODUCTION 121 14.2 NORTH AMERICA 122 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 122 14.2.2 US 124 14.2.2.1 Early adoption of advanced medical technologies to support market growth 124 14.2.3 CANADA 125 14.2.3.1 Government funding and healthcare innovation to drive Canadian nanorobotics market 125 14.2.4 MEXICO 126 14.2.4.1 Strategic partnerships and nanotechnology platforms to fuel market growth 126   14.3 EUROPE 127 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 127 14.3.2 UK 129 14.3.2.1 Growing nanotechnology development programs to boost market demand 129 14.3.3 GERMANY 130 14.3.3.1 Growing nanotechnology research to improve market growth 130 14.3.4 FRANCE 131 14.3.4.1 Investments in research & development to fuel market growth 131 14.3.5 ITALY 132 14.3.5.1 Rising focus on precision healthcare and research infrastructure to support market growth 132 14.3.6 REST OF EUROPE 133 14.4 ASIA PACIFIC 134 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 134 14.4.2 CHINA 136 14.4.2.1 Growing number of collaborations for R&D in nanotechnology and life sciences to drive market 136 14.4.3 JAPAN 137 14.4.3.1 Rising R&D funding for biotechnology and nanotechnology to support market growth 137 14.4.4 INDIA 138 14.4.4.1 Increasing demand for advanced medical treatments to drive market 138 14.4.5 SOUTH KOREA 139 14.4.5.1 Increasing use in medical research and healthcare applications to fuel market demand 139 14.4.6 REST OF ASIA PACIFIC 140 14.5 REST OF THE WORLD 141 14.5.1 MACROECONOMIC OUTLOOK FOR REST OF THE WORLD 141 14.5.2 MIDDLE EAST & AFRICA 142 14.5.2.1 Rising oil & gas exploration activities to accelerate market growth 142 14.5.2.2 GCC countries 144 14.5.2.3 Rest of Middle East & Africa 144 14.5.3 SOUTH AMERICA 144 14.5.3.1 Growth in automotive, oil & gas, chemicals, and mining industries to augment market demand 144 15 COMPETITIVE LANDSCAPE 146 15.1 INTRODUCTION 146 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 146 15.3 MARKET SHARE ANALYSIS, 2024 147 15.4 REVENUE ANALYSIS, 2022–2024 149 15.5 COMPANY VALUATION & FINANCIAL METRICS 150 15.5.1 COMPANY VALUATION 150 15.5.2 FINANCIAL METRICS 150 15.6 BRAND/PRODUCT COMPARISON 151 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 151 15.7.1 STARS 151 15.7.2 EMERGING LEADERS 151 15.7.3 PERVASIVE PLAYERS 152 15.7.4 PARTICIPANTS 152 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 153 15.7.5.1 Company footprint 153 15.7.5.2 Region footprint 153 15.7.5.3 Type footprint 154 15.7.5.4 Deployment footprint 155 15.7.5.5 End-user footprint 155 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 156 15.8.1 PROGRESSIVE COMPANIES 156 15.8.2 RESPONSIVE COMPANIES 156 15.8.3 DYNAMIC COMPANIES 156 15.8.4 STARTING BLOCKS 156 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 157 15.8.5.1 Detailed list of key startups/SMEs 157 15.8.5.2 Competitive benchmarking of key startups/SMEs 158 15.9 COMPETITIVE SCENARIO 159 15.9.1 PRODUCT LAUNCHES 159 15.9.2 DEALS 160 15.9.3 OTHER DEVELOPMENTS 161 16 COMPANY PROFILES 162 16.1 KEY PLAYERS 162 16.1.1 BRUKER 162 16.1.1.1 Business overview 162 16.1.1.2 Products/Solutions/Services offered 163 16.1.1.3 Recent developments 164 16.1.1.3.1 Product launches 164 16.1.1.3.2 Deals 164 16.1.1.4 MnM view 165 16.1.1.4.1 Key strengths 165 16.1.1.4.2 Strategic choices 165 16.1.1.4.3 Weaknesses & competitive threats 165 16.1.2 JEOL LTD. 166 16.1.2.1 Business overview 166 16.1.2.2 Products/Solutions/Services offered 167 16.1.2.3 Recent developments 167 16.1.2.3.1 Product launches 167 16.1.2.4 MnM view 168 16.1.2.4.1 Key strengths 168 16.1.2.4.2 Strategic choices 168 16.1.2.4.3 Weaknesses & competitive threats 168 16.1.3 THERMO FISHER SCIENTIFIC INC. 169 16.1.3.1 Business overview 169 16.1.3.2 Products/Solutions/Services offered 170 16.1.3.3 Recent developments 171 16.1.3.3.1 Product launches 171 16.1.3.4 MnM view 171 16.1.3.4.1 Key strengths 171 16.1.3.4.2 Strategic choices 171 16.1.3.4.3 Weaknesses & competitive threats 171 16.1.4 HITACHI HIGH-TECH CORPORATION 172 16.1.4.1 Business overview 172 16.1.4.2 Products/Solutions/Services offered 173 16.1.4.3 Recent developments 174 16.1.4.3.1 Product launches 174 16.1.4.3.2 Deals 175 16.1.4.4 MnM view 175 16.1.4.4.1 Key strengths 175 16.1.4.4.2 Strategic choices 175 16.1.4.4.3 Weaknesses & competitive threats 175 16.1.5 ZEISS GROUP 176 16.1.5.1 Business overview 176 16.1.5.2 Products/Solutions/Services offered 177 16.1.5.3 Recent developments 178 16.1.5.3.1 Product launches 178 16.1.5.3.2 Deals 178 16.1.5.3.3 Expansions 179 16.1.5.4 MnM view 179 16.1.5.4.1 Key strengths 179 16.1.5.4.2 Strategic choices 179 16.1.5.4.3 Weaknesses & competitive threats 179 16.1.6 PARK SYSTEMS 180 16.1.6.1 Business overview 180 16.1.6.2 Products/Solutions/Services offered 181 16.1.6.3 Recent developments 181 16.1.6.3.1 Product launches 181 16.1.6.3.2 Deals 181 16.1.6.3.3 Expansions 182 16.1.7 OXFORD INSTRUMENTS 183 16.1.7.1 Business overview 183 16.1.7.2 Products/Solutions/Services offered 184 16.1.8 EV GROUP (EVG) 185 16.1.8.1 Business overview 185 16.1.8.2 Products/Solutions/Services offered 185 16.1.9 THERANAUTILUS 186 16.1.9.1 Business overview 186 16.1.9.2 Products/Solutions/Services offered 186 16.1.10 CIQTEK CO., LTD. 187 16.1.10.1 Business overview 187 16.1.10.2 Products/Solutions/Services offered 187 16.1.10.3 Recent developments 188 16.1.10.3.1 Product launches 188 16.1.10.3.2 Deals 188 16.2 OTHER PLAYERS 189 16.2.1 IMINA TECHNOLOGIES SA 189 16.2.2 NANOBIOTIX 189 16.2.3 NANOLIVE 190 16.2.4 TORONTO NANO INSTRUMENTATION INC. 190 16.2.5 KLOCKE NANOTECHNIK GMBH 191 16.2.6 KLEINDIEK NANOTECHNIK GMBH 192 16.2.7 SMARACT GMBH 192 16.2.8 NANOSURF 193 16.2.9 GINKGO BIOWORKS 193 16.2.10 STEREOTAXIS, INC. 194 16.2.11 BIONAUT LABS, INC. 195 16.2.12 NOVASCAN TECHNOLOGIES, INC. 195 16.2.13 DNA NANOBOTS, INC. 196 16.2.14 ANGSTROM ADVANCED INC. 196 16.2.15 NENOVISION S.R.O. 197 17 RESEARCH METHODOLOGY 198 17.1 RESEARCH DATA 198 17.1.1 SECONDARY DATA 199 17.1.1.1 List of key secondary sources 199 17.1.1.2 Key data from secondary sources 199 17.1.2 PRIMARY DATA 200 17.1.2.1 List of primary interview participants 200 17.1.2.2 Breakdown of primaries 200 17.1.2.3 Key industry insights 201   17.1.3 SECONDARY AND PRIMARY RESEARCH 201 17.2 MARKET SIZE ESTIMATION 202 17.2.1 BOTTOM-UP APPROACH 202 17.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side) 202 17.2.2 TOP-DOWN APPROACH 204 17.2.2.1 Approach to arrive at market size using top-down analysis (supply side) 204 17.3 DATA TRIANGULATION 205 17.4 STUDY ASSUMPTIONS 206 17.5 RISK ANALYSIS 207 17.6 RESEARCH LIMITATIONS 207 18 APPENDIX 208 18.1 DISCUSSION GUIDE 208 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 211 18.3 CUSTOMIZATION OPTIONS 213 18.4 RELATED REPORTS 213 18.5 AUTHOR DETAILS 214
圖表清單 List of Tables & Figures
TABLE 1 NANOROBOTICS MARKET: INCLUSIONS & EXCLUSIONS 26 TABLE 2 NANOROBOTICS MARKET: IMPACT OF PORTER’S FIVE FORCES 42 TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 44 TABLE 4 COMPANIES AND THEIR ROLE IN NANOROBOTICS ECOSYSTEM 48 TABLE 5 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES OFFERED BY KEY PLAYERS, BY TYPE, 2025 50 TABLE 6 IMPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020–2024 (USD MILLION) 52 TABLE 7 EXPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020–2024 (USD MILLION) 53 TABLE 8 KEY CONFERENCES & EVENTS IN NANOROBOTICS MARKET, JANUARY 2026–DECEMBER 2027 53 TABLE 9 KLEINDIEK NANOTECHNIK ENABLING IN-SITU NANO-MANIPULATION INSIDE SEM AND TEM 56 TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES 57 TABLE 11 EVOLUTION OF NANOROBOTICS TECHNOLOGIES 62 TABLE 12 LIST OF APPLIED/GRANTED PATENTS IN NANOROBOTICS MARKET, 2021–2025 64 TABLE 13 TOP USE CASES AND NANOROBOTICS MARKET POTENTIAL 66 TABLE 14 BEST PRACTICES FOR COMPANIES IMPLEMENTING USE CASES 67 TABLE 15 CASE STUDIES RELATED TO AI IMPLEMENTATION IN NANOROBOTICS MARKET 67 TABLE 16 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 67 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%) 73 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 74 TABLE 23 UNMET NEEDS IN NANOROBOTICS MARKE, BY END USER 76 TABLE 24 NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 78 TABLE 25 NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 78 TABLE 26 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 79 TABLE 27 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 79 TABLE 28 NANO-MANIPULATORS: NANOROBOTICS MARKET FOR ELECTRON MICROSCOPY, BY TYPE, 2022–2025 (MILLION UNITS) 79 TABLE 29 NANO-MANIPULATORS: NANOROBOTICS MARKET FOR ELECTRON MICROSCOPY, BY TYPE, 2026–2032 (MILLION UNITS) 80 TABLE 30 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 80 TABLE 31 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY APPLICATION, 2026–2032 (USD MILLION) 80 TABLE 32 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 81 TABLE 33 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 81 TABLE 34 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY DEPLOYMENT, 2022–2025 (USD MILLION) 81 TABLE 35 NANO-MANIPULATORS: NANOROBOTICS MARKET, BY DEPLOYMENT, 2026–2032 (USD MILLION) 82 TABLE 36 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 82 TABLE 37 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY APPLICATION, 2026–2032 (USD MILLION) 83 TABLE 38 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 83 TABLE 39 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 83 TABLE 40 NANOROBOTIC SYSTEMS: NANOROBOTICS MARKET, BY DEPLOYMENT, 2022–2025 (USD MILLION) 84 TABLE 41 NANOROBOTICS SYSTEMS: NANOROBOTICS MARKET, BY DEPLOYMENT, 2026–2032 (USD MILLION) 84 TABLE 42 NANOROBOTICS MARKET, BY TECHNOLOGY, 2022–2025 (USD MILLION) 86 TABLE 43 NANOROBOTICS MARKET, BY TECHNOLOGY, 2026–2032 (USD MILLION) 87 TABLE 44 NANOROBOTICS MARKET, BY DEPLOYMENT, 2022–2025 (USD MILLION) 90 TABLE 45 NANOROBOTICS MARKET, BY DEPLOYMENT, 2026–2032 (USD MILLION) 90 TABLE 46 IN-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 91 TABLE 47 IN-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 91 TABLE 48 IN-VITRO/EX-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 92 TABLE 49 IN-VITRO/EX-VIVO DEPLOYMENT: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 92 TABLE 50 OTHER DEPLOYMENTS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 92 TABLE 51 OTHER DEPLOYMENTS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 92 TABLE 52 NANOROBOTICS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 94 TABLE 53 NANOROBOTICS MARKET, BY APPLICATION, 2026–2032 (USD MILLION) 95 TABLE 54 DIAGNOSTICS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 95 TABLE 55 DIAGNOSTICS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 95 TABLE 56 DRUG DELIVERY: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 96 TABLE 57 DRUG DELIVERY: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 96 TABLE 58 NANO SURGERY & TISSUE REPAIR: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 97 TABLE 59 NANO SURGERY & TISSUE REPAIR: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 97 TABLE 60 OTHER APPLICATIONS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 97 TABLE 61 OTHER APPLICATIONS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 97 TABLE 62 NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 99 TABLE 63 NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 100 TABLE 64 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 100 TABLE 65 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 101 TABLE 66 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 101 TABLE 67 RESEARCH INSTITUTES & UNIVERSITIES: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 101 TABLE 68 RESEARCH INSTITUTES & UNIVERSITIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 102 TABLE 69 RESEARCH INSTITUTES & UNIVERSITIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 102 TABLE 70 RESEARCH INSTITUTES & UNIVERSITIES: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 102 TABLE 71 RESEARCH INSTITUTES & UNIVERSITIES: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 103 TABLE 72 RESEARCH INSTITUTES & UNIVERSITIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 103 TABLE 73 RESEARCH INSTITUTES & UNIVERSITIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 103 TABLE 74 RESEARCH INSTITUTES & UNIVERSITIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 104 TABLE 75 RESEARCH INSTITUTES & UNIVERSITIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 104 TABLE 76 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 104 TABLE 77 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 105 TABLE 78 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 105 TABLE 79 HOSPITALS & CLINICAL CENTERS: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 105 TABLE 80 HOSPITALS & CLINICAL CENTERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 106 TABLE 81 HOSPITALS & CLINICAL CENTERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 106 TABLE 82 HOSPITALS & CLINICAL CENTERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 106 TABLE 83 HOSPITALS & CLINICAL CENTERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 107 TABLE 84 HOSPITALS & CLINICAL CENTERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 107 TABLE 85 HOSPITALS & CLINICAL CENTERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 107 TABLE 86 HOSPITALS & CLINICAL CENTERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 108 TABLE 87 HOSPITALS & CLINICAL CENTERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 108 TABLE 88 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 108 TABLE 89 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 109 TABLE 90 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 109 TABLE 91 PHARMA & BIOTECH COMPANIES: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 109 TABLE 92 PHARMA & BIOTECH COMPANIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 110 TABLE 93 PHARMA & BIOTECH COMPANIES: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 110 TABLE 94 PHARMA & BIOTECH COMPANIES: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 110 TABLE 95 PHARMA & BIOTECH COMPANIES: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 111 TABLE 96 PHARMA & BIOTECH COMPANIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 111 TABLE 97 PHARMA & BIOTECH COMPANIES: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 111 TABLE 98 PHARMA & BIOTECH COMPANIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 112 TABLE 99 PHARMA & BIOTECH COMPANIES: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 112 TABLE 100 MEDICAL OEMS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 112 TABLE 101 MEDICAL OEMS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 112 TABLE 102 MEDICAL OEMS: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 113 TABLE 103 MEDICAL OEMS: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 113 TABLE 104 MEDICAL OEMS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 113 TABLE 105 MEDICAL OEMS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 114 TABLE 106 MEDICAL OEMS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 114 TABLE 107 MEDICAL OEMS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 114 TABLE 108 MEDICAL OEMS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 115 TABLE 109 MEDICAL OEMS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 115 TABLE 110 MEDICAL OEMS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 115 TABLE 111 MEDICAL OEMS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 115 TABLE 112 OTHER END USERS: NANOROBOTICS MARKET, BY TYPE, 2022–2025 (USD MILLION) 116 TABLE 113 OTHER END USERS: NANOROBOTICS MARKET, BY TYPE, 2026–2032 (USD MILLION) 116 TABLE 114 OTHER END USERS: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 116 TABLE 115 OTHER END USERS: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 117 TABLE 116 OTHER END USERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 117 TABLE 117 OTHER END USERS: NORTH AMERICA NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 117 TABLE 118 OTHER END USERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 118 TABLE 119 OTHER END USERS: EUROPE NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 118 TABLE 120 OTHER END USERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 118 TABLE 121 OTHER END USERS: ASIA PACIFIC NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 119 TABLE 122 OTHER END USERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 119 TABLE 123 OTHER END USERS: ROW NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 119 TABLE 124 NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 121 TABLE 125 NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 122 TABLE 126 NORTH AMERICA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 123 TABLE 127 NORTH AMERICA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 124 TABLE 128 NORTH AMERICA: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 124 TABLE 129 NORTH AMERICA: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 124 TABLE 130 US: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 125 TABLE 131 US: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 125 TABLE 132 CANADA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 126 TABLE 133 CANADA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 126 TABLE 134 MEXICO: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 127 TABLE 135 MEXICO: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 127 TABLE 136 EUROPE: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 128 TABLE 137 EUROPE: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 129 TABLE 138 EUROPE: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 129 TABLE 139 EUROPE: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 129 TABLE 140 UK: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 130 TABLE 141 UK: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 130 TABLE 142 GERMANY: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 131 TABLE 143 GERMANY: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 131 TABLE 144 FRANCE: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 132 TABLE 145 FRANCE: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 132 TABLE 146 ITALY: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 132 TABLE 147 ITALY: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 133 TABLE 148 REST OF EUROPE: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 133 TABLE 149 REST OF EUROPE: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 133 TABLE 150 ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 135 TABLE 151 ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 136 TABLE 152 ASIA PACIFIC: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 136 TABLE 153 ASIA PACIFIC: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 136 TABLE 154 CHINA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 137 TABLE 155 CHINA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 137 TABLE 156 JAPAN: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 138 TABLE 157 JAPAN: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 138 TABLE 158 INDIA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 139 TABLE 159 INDIA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 139 TABLE 160 SOUTH KOREA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 140 TABLE 161 SOUTH KOREA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 140 TABLE 162 REST OF ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 140 TABLE 163 REST OF ASIA PACIFIC: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 141 TABLE 164 REST OF THE WORLD: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 141 TABLE 165 REST OF THE WORLD: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 142 TABLE 166 REST OF THE WORLD: NANOROBOTICS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 142 TABLE 167 REST OF THE WORLD: NANOROBOTICS MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 142 TABLE 168 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 143 TABLE 169 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 143 TABLE 170 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY REGION, 2022–2025 (USD MILLION) 143 TABLE 171 MIDDLE EAST & AFRICA: NANOROBOTICS MARKET, BY REGION, 2026–2032 (USD MILLION) 144 TABLE 172 SOUTH AMERICA: NANOROBOTICS MARKET, BY END USER, 2022–2025 (USD MILLION) 144 TABLE 173 SOUTH AMERICA: NANOROBOTICS MARKET, BY END USER, 2026–2032 (USD MILLION) 145 TABLE 174 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NANOROBOTICS MARKET, JANUARY 2021–DECEMBER 2025 146 TABLE 175 MARKET SHARE ANALYSIS OF TOP FIVE PLAYERS IN NANOROBOTICS MARKET, 2024 147 TABLE 176 NANOROBOTICS MARKET: REGION FOOTPRINT 153 TABLE 177 NANOROBOTICS MARKET: TYPE FOOTPRINT 154 TABLE 178 NANOROBOTICS MARKET: DEPLOYMENT FOOTPRINT 155 TABLE 179 NANOROBOTICS MARKET: END-USER FOOTPRINT 155 TABLE 180 NANOROBOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 157 TABLE 181 NANOROBOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE, END USER, AND REGION 158 TABLE 182 NANOROBOTICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2025 159 TABLE 183 NANOROBOTICS MARKET: DEALS, JANUARY 2021–DECEMBER 2025 160 TABLE 184 NANOROBOTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 161 TABLE 185 BRUKER: COMPANY OVERVIEW 162 TABLE 186 BRUKER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 163 TABLE 187 BRUKER: PRODUCT LAUNCHES 164 TABLE 188 BRUKER: DEALS 164 TABLE 189 JEOL LTD.: COMPANY OVERVIEW 166 TABLE 190 JEOL LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 167 TABLE 191 JEOL LTD.: PRODUCT LAUNCHES 167 TABLE 192 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 169 TABLE 193 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 170 TABLE 194 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 171 TABLE 195 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW 172 TABLE 196 HITACHI HIGH-TECH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 173 TABLE 197 HITACHI HIGH-TECH CORPORATION: PRODUCT LAUNCHES 174 TABLE 198 HITACHI HIGH-TECH CORPORATION: DEALS 175 TABLE 199 ZEISS GROUP: COMPANY OVERVIEW 176 TABLE 200 ZEISS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 177 TABLE 201 ZEISS GROUP: PRODUCT LAUNCHES 178 TABLE 202 ZEISS GROUP: DEALS 178 TABLE 203 ZEISS GROUP: EXPANSIONS 179 TABLE 204 PARK SYSTEMS: COMPANY OVERVIEW 180 TABLE 205 PARK SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 181 TABLE 206 PARK SYSTEMS: PRODUCT LAUNCHES 181 TABLE 207 PARK SYSTEMS: DEALS 181 TABLE 208 PARK SYSTEMS: EXPANSIONS 182 TABLE 209 OXFORD INSTRUMENTS: COMPANY OVERVIEW 183 TABLE 210 OXFORD INSTRUMENTS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184 TABLE 211 EV GROUP (EVG): COMPANY OVERVIEW 185 TABLE 212 EV GROUP (EVG): PRODUCTS/SOLUTIONS/SERVICES OFFERED 185 TABLE 213 THERANAUTILUS: COMPANY OVERVIEW 186 TABLE 214 THERANAUTILUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 186 TABLE 215 CIQTEK CO., LTD.: COMPANY OVERVIEW 187 TABLE 216 CIQTEK CO.,LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187 TABLE 217 CIQTEK CO.,LTD.: PRODUCT LAUNCHES 188 TABLE 218 CIQTEK CO.,LTD.: DEALS 188 TABLE 219 IMINA TECHNOLOGIES SA: COMPANY OVERVIEW 189 TABLE 220 NANOBIOTIX: COMPANY OVERVIEW 189 TABLE 221 NANOLIVE: COMPANY OVERVIEW 190 TABLE 222 TORONTO NANO INSTRUMENTATION INC.: COMPANY OVERVIEW 190 TABLE 223 KLOCKE NANOTECHNIK GMBH: COMPANY OVERVIEW 191 TABLE 224 KLEINDIEK NANOTECHNIK GMBH: COMPANY OVERVIEW 192 TABLE 225 SMARACT GMBH: COMPANY OVERVIEW 192 TABLE 226 NANOSURF: COMPANY OVERVIEW 193 TABLE 227 GINKGO BIOWORKS: COMPANY OVERVIEW 193 TABLE 228 STEREOTAXIS, INC.: COMPANY OVERVIEW 194 TABLE 229 BIONAUT LABS, INC.:COMPANY OVERVIEW 195 TABLE 230 NOVASCAN TECHNOLOGIES, INC.: COMPANY OVERVIEW 195 TABLE 231 DNA NANOBOTS, INC.: COMPANY OVERVIEW 196 TABLE 232 ANGSTROM ADVANCED INC.: COMPANY OVERVIEW 196 TABLE 233 NENOVISION S.R.O.: COMPANY OVERVIEW 197 TABLE 234 LIST OF KEY SECONDARY SOURCES IN NANOROBOTICS MARKET 199 TABLE 235 LIST OF PRIMARY INTERVIEW PARTICIPANTS IN NANOROBOTICS MARKET 200 TABLE 236 NANOROBOTICS MARKET: STUDY ASSUMPTIONS 206 TABLE 237 NANOROBOTICS MARKET: RISK ANALYSIS 207 FIGURE 1 NANOROBOTICS MARKET SEGMENTATION & REGIONAL SCOPE 25 FIGURE 2 NANOROBOTICS MARKET: YEARS CONSIDERED 26 FIGURE 3 KEY INSIGHTS & MARKET SCENARIO 28 FIGURE 4 GLOBAL NANOROBOTICS MARKET, IN TERMS OF VALUE, 2026–2032 (USD MILLION) 28 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NANOROBOTICS MARKET, JANUARY 2022–DECEMBER 2025 29 FIGURE 6 DISRUPTIVE TRENDS INFLUENCING COMMON-MODE CHOKE DEMAND 30 FIGURE 7 HIGH-GROWTH SEGMENTS IN NANOROBOTICS MARKET, BY TYPE, DEPLOYMENT, END USER, AND REGION 30 FIGURE 8 ASIA PACIFIC TO BE LEADING MARKET DURING FORECAST PERIOD 31 FIGURE 9 RISING FOCUS ON NANOTECHNOLOGY AND REGENERATIVE MEDICINES TO FUEL MARKET GROWTH 32 FIGURE 10 NANO-MANIPULATORS TO CAPTURE LARGEST MARKET SHARE BY 2032 32 FIGURE 11 DIAGNOSTICS TO ACCOUNT FOR LARGEST MARKET SHARE BY 2032 33 FIGURE 12 MAGNETIC ACTUATION TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 33 FIGURE 13 RESEARCH INSTITUTES & UNIVERSITIES TO BE LARGEST END USERS OF NANOROBOTICS FROM 2026 TO 2032 34 FIGURE 14 INDIA TO REGISTER HIGHEST CAGR IN NANOROBOTICS MARKET BETWEEN 2026 AND 2032 34 FIGURE 15 NANOROBOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35 FIGURE 16 NANOROBOTICS MARKET: DRIVERS AND THEIR IMPACT 36 FIGURE 17 NANOROBOTICS MARKET: RESTRAINTS AND THEIR IMPACT 37 FIGURE 18 NANOROBOTICS MARKET: OPPORTUNITIES AND THEIR IMPACT 38 FIGURE 19 NANOROBOTICS MARKET: CHALLENGES AND THEIR IMPACT 39 FIGURE 20 NANOROBOTICS MARKET: PORTER'S FIVE FORCES ANALYSIS 43 FIGURE 21 NANOROBOTICS MARKET: VALUE CHAIN ANALYSIS 46 FIGURE 22 NANOROBOTICS MARKET: ECOSYSTEM ANALYSIS 48 FIGURE 23 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES, BY TYPE, 2025 (USD THOUSAND) 49 FIGURE 24 AVERAGE SELLING PRICE OF ELECTRON MICROSCOPES, BY TYPE, 2022–2025 (USD THOUSAND) 50 FIGURE 25 AVERAGE SELLING PRICE OF SEM ELECTRON MICROSCOPES, BY REGION, 2022–2025 (USD) 51 FIGURE 26 IMPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020−2024 (USD MILLION) 51 FIGURE 27 EXPORT DATA FOR HS CODE 901210, BY COUNTRY, 2020−2024 (USD MILLION) 52 FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN NANOROBOTICS MARKET 55 FIGURE 29 FUNDING SCENARIO IN NANOROBOTICS MARKET, 2023–2025 (USD MILLION) 56 FIGURE 30 NANOROBOTICS MARKET: PATENT ANALYSIS, 2015–2024 64 FIGURE 31 DECISION-MAKING FACTORS IN NANOROBOTICS MARKET 72 FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 73 FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 74 FIGURE 34 ADOPTION BARRIERS & INTERNAL CHALLENGES 75 FIGURE 35 NANOROBOTIC SYSTEMS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 78 FIGURE 36 MAGNETIC ACTUATION TO ACCOUNT FOR LARGEST MARKET SHARE BY 2032 86 FIGURE 37 IN-VIVO DEPLOYMENT TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 90 FIGURE 38 DIAGNOSTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 94 FIGURE 39 RESEARCH INSTITUTES & UNIVERSITIES TO COMMAND LARGEST MARKET SHARE 99 FIGURE 40 NANOROBOTICS MARKET, BY REGION, 2026 VS. 2032 (USD MILLION) 121 FIGURE 41 NORTH AMERICA: NANOROBOTICS MARKET SNAPSHOT 123 FIGURE 42 EUROPE: NANOROBOTICS MARKET SNAPSHOT 128 FIGURE 43 ASIA PACIFIC: NANOROBOTICS MARKET SNAPSHOT 135 FIGURE 44 NANOROBOTICS MARKET SHARE ANALYSIS (2024) 148 FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN NANOROBOTICS MARKET, 2022–2024 149 FIGURE 46 NANOROBOTICS MARKET: COMPANY VALUATION 150 FIGURE 47 NANOROBOTICS MARKET: FINANCIAL METRICS 150 FIGURE 48 NANOROBOTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 151 FIGURE 49 NANOROBOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 152 FIGURE 50 NANOROBOTICS MARKET: COMPANY FOOTPRINT 153 FIGURE 51 NANOROBOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 157 FIGURE 52 BRUKER: COMPANY SNAPSHOT 163 FIGURE 53 JEOL LTD.: COMPANY SNAPSHOT 166 FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 170 FIGURE 55 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT 173 FIGURE 56 ZEISS GROUP: COMPANY SNAPSHOT 177 FIGURE 57 PARK SYSTEMS: COMPANY SNAPSHOT 180 FIGURE 58 OXFORD INSTRUMENTS: COMPANY SNAPSHOT 184 FIGURE 59 NANOROBOTICS MARKET: RESEARCH DESIGN 198 FIGURE 60 KEY DATA FROM SECONDARY SOURCES IN NANOROBOTICS MARKET 199 FIGURE 61 NANOROBOTICS MARKET: BREAKDOWN OF PRIMARIES 200 FIGURE 62 KEY INSIGHTS FROM INDUSTRY EXPERTS IN NANOROBOTICS MARKET 201 FIGURE 63 SECONDARY AND PRIMARY RESEARCH IN NANOROBOTICS MARKET 201 FIGURE 64 RESEARCH FLOW IN NANOROBOTICS MARKET 202 FIGURE 65 NANOROBOTICS MARKET: BOTTOM-UP APPROACH 203 FIGURE 66 NANOROBOTICS MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE) 203 FIGURE 67 NANOROBOTICS MARKET: TOP-DOWN APPROACH 204 FIGURE 68 NANOROBOTICS MARKET: DATA TRIANGULATION 205

同分類最新報告（電子與半導體）

查看電子與半導體全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們